Nifedipine API Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4162631
- 99 Pages
- January 2020
- Medical Devices
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Nifedipine API market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Nifedipine API market segmented into
98% Nifedipine API
99% Nifedipine API
99.9% Nifedipine API
Based on the end-use, the global Nifedipine API market classified into
Controlled Release Tablets
Extended Action Tablets
Modified Release Capsule
Based on geography, the global Nifedipine API market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Bayer AG
ZACH SYSTEM SPA
Teva Group
Dipharma Francis S.r.l.
Delmar Chemicals Inc.
Moehs Iberica S.L.
Sumika Fine Chemicals Co., Ltd.
CIPLA Ltd
Dipharma Francis S.r.l
Tecoland Corp
Zhong'an Pharmaceutical
Siyao Pharmaceuticals
Xiyue Pharmaceutical
Qingyang Pharmaceutical
Luyin Pharmaceutical
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NIFEDIPINE API INDUSTRY
2.1 Summary about Nifedipine API Industry
2.2 Nifedipine API Market Trends
2.2.1 Nifedipine API Production & Consumption Trends
2.2.2 Nifedipine API Demand Structure Trends
2.3 Nifedipine API Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 98% Nifedipine API
4.2.2 99% Nifedipine API
4.2.3 99.9% Nifedipine API
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Controlled Release Tablets
4.3.2 Extended Action Tablets
4.3.3 Modified Release Capsule
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 98% Nifedipine API
5.2.2 99% Nifedipine API
5.2.3 99.9% Nifedipine API
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Controlled Release Tablets
5.3.2 Extended Action Tablets
5.3.3 Modified Release Capsule
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 98% Nifedipine API
6.2.2 99% Nifedipine API
6.2.3 99.9% Nifedipine API
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Controlled Release Tablets
6.3.2 Extended Action Tablets
6.3.3 Modified Release Capsule
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 98% Nifedipine API
7.2.2 99% Nifedipine API
7.2.3 99.9% Nifedipine API
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Controlled Release Tablets
7.3.2 Extended Action Tablets
7.3.3 Modified Release Capsule
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 98% Nifedipine API
8.2.2 99% Nifedipine API
8.2.3 99.9% Nifedipine API
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Controlled Release Tablets
8.3.2 Extended Action Tablets
8.3.3 Modified Release Capsule
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 98% Nifedipine API
9.2.2 99% Nifedipine API
9.2.3 99.9% Nifedipine API
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Controlled Release Tablets
9.3.2 Extended Action Tablets
9.3.3 Modified Release Capsule
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Bayer AG
10.1.2 ZACH SYSTEM SPA
10.1.3 Teva Group
10.1.4 Dipharma Francis S.r.l.
10.1.5 Delmar Chemicals Inc.
10.1.6 Moehs Iberica S.L.
10.1.7 Sumika Fine Chemicals Co., Ltd.
10.1.8 CIPLA Ltd
10.1.9 Dipharma Francis S.r.l
10.1.10 Tecoland Corp
10.1.11 Zhong'an Pharmaceutical
10.1.12 Siyao Pharmaceuticals
10.1.13 Xiyue Pharmaceutical
10.1.14 Qingyang Pharmaceutical
10.1.15 Luyin Pharmaceutical
10.2 Nifedipine API Sales Date of Major Players (2017-2020e)
10.2.1 Bayer AG
10.2.2 ZACH SYSTEM SPA
10.2.3 Teva Group
10.2.4 Dipharma Francis S.r.l.
10.2.5 Delmar Chemicals Inc.
10.2.6 Moehs Iberica S.L.
10.2.7 Sumika Fine Chemicals Co., Ltd.
10.2.8 CIPLA Ltd
10.2.9 Dipharma Francis S.r.l
10.2.10 Tecoland Corp
10.2.11 Zhong'an Pharmaceutical
10.2.12 Siyao Pharmaceuticals
10.2.13 Xiyue Pharmaceutical
10.2.14 Qingyang Pharmaceutical
10.2.15 Luyin Pharmaceutical
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Nifedipine API Product Type Overview
2.Table Nifedipine API Product Type Market Share List
3.Table Nifedipine API Product Type of Major Players
4.Table Brief Introduction of Bayer AG
5.Table Brief Introduction of ZACH SYSTEM SPA
6.Table Brief Introduction of Teva Group
7.Table Brief Introduction of Dipharma Francis S.r.l.
8.Table Brief Introduction of Delmar Chemicals Inc.
9.Table Brief Introduction of Moehs Iberica S.L.
10.Table Brief Introduction of Sumika Fine Chemicals Co., Ltd.
11.Table Brief Introduction of CIPLA Ltd
12.Table Brief Introduction of Dipharma Francis S.r.l
13.Table Brief Introduction of Tecoland Corp
14.Table Brief Introduction of Zhong'an Pharmaceutical
15.Table Brief Introduction of Siyao Pharmaceuticals
16.Table Brief Introduction of Xiyue Pharmaceutical
17.Table Brief Introduction of Qingyang Pharmaceutical
18.Table Brief Introduction of Luyin Pharmaceutical
19.Table Products & Services of Bayer AG
20.Table Products & Services of ZACH SYSTEM SPA
21.Table Products & Services of Teva Group
22.Table Products & Services of Dipharma Francis S.r.l.
23.Table Products & Services of Delmar Chemicals Inc.
24.Table Products & Services of Moehs Iberica S.L.
25.Table Products & Services of Sumika Fine Chemicals Co., Ltd.
26.Table Products & Services of CIPLA Ltd
27.Table Products & Services of Dipharma Francis S.r.l
28.Table Products & Services of Tecoland Corp
29.Table Products & Services of Zhong'an Pharmaceutical
30.Table Products & Services of Siyao Pharmaceuticals
31.Table Products & Services of Xiyue Pharmaceutical
32.Table Products & Services of Qingyang Pharmaceutical
33.Table Products & Services of Luyin Pharmaceutical
34.Table Market Distribution of Major Players
35.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
36.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
37.Table Global Nifedipine API Market Forecast (Million USD) by Region 2021f-2026f
38.Table Global Nifedipine API Market Forecast (Million USD) Share by Region 2021f-2026f
39.Table Global Nifedipine API Market Forecast (Million USD) by Demand 2021f-2026f
40.Table Global Nifedipine API Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
